Articles by Daniel Marsh
Moderna Jumps 10% as Cancer Vaccine Trial Hits Key Goals
Moderna shares surged 9.93% after its cancer vaccine intismeran met two Phase 3 endpoints, adding $5.6B in market value. Full efficacy data remain undisclosed.
Reitar Debt Conversion Dilutes Shares as Stock Slips to $0.09
Reitar Logtech shares dropped 2.2% to $0.09 after converting $2.2 million in debt to equity, representing 39% of market value. Investors face dilution as Nasdaq compliance deadline approaches.
Fly-E Group Stock Soars 58% on Massive Volume Despite Weak Fundamentals
Fly-E Group (FLYE) rallied 58% to $2.17 on record volume, but the move comes amid a 48% revenue drop and going-concern doubts.
Live Nation Slips as Ticketmaster Promo Highlights Profit Engine
Live Nation shares dipped 0.8% as Ticketmaster's $20 ticket promotion highlighted its 41% share of adjusted operating income. The promo underscores the ticketing division's outsized profitability.
Trump Media Shares Slide 7% as Valuation Premium Persists
Trump Media shares dropped 7% to $9.09, but the $2.5B valuation still stands 147% above book value, reflecting high expectations.
Whirlpool Stock Tumbles on Debt Woes and Housing Slump
Whirlpool (WHR) shares dropped 7.8% as its $7.1 billion debt burden and a struggling housing market raised investor concerns about leverage.
PG&E Rebounds 3.7% on Wildfire Bill, But Funding Gap Persists
PG&E (PCG) shares recovered 3.7% Tuesday after California lawmakers advanced wildfire funding legislation, but analysts warn the bill leaves a significant capital gap unresolved.
Stellantis Shares Slide 3% as Canadian Labor Talks Test Margin Recovery
Stellantis (STLA) shares dropped 3% amid Canadian labor negotiations, as investors weigh cost pressures against the automaker's margin recovery efforts.



